vs
Side-by-side financial comparison of LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) and REGIS CORP (RGS). Click either name above to swap in a different company.
REGIS CORP is the larger business by last-quarter revenue ($57.1M vs $31.1M, roughly 1.8× LIFECORE BIOMEDICAL, INC. \DE\). REGIS CORP runs the higher net margin — 0.8% vs -32.1%, a 32.9% gap on every dollar of revenue. On growth, REGIS CORP posted the faster year-over-year revenue change (22.3% vs -4.5%). REGIS CORP produced more free cash flow last quarter ($891.0K vs $25.0K). Over the past eight quarters, REGIS CORP's revenue compounded faster (7.8% CAGR vs -0.1%).
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
REGIS CORPRGSEarnings & Financial Report
Regis Corporation is an American operator of hair salons. As of August 2021, it has 5,563 franchised and 276 company-owned salons. Its headquarters are in Minneapolis, Minnesota.
LFCR vs RGS — Head-to-Head
Income Statement — Q2 FY2026 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $31.1M | $57.1M |
| Net Profit | $-10.0M | $456.0K |
| Gross Margin | 25.0% | — |
| Operating Margin | -9.9% | 10.8% |
| Net Margin | -32.1% | 0.8% |
| Revenue YoY | -4.5% | 22.3% |
| Net Profit YoY | -52.0% | -94.0% |
| EPS (diluted) | $-0.29 | $0.16 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $57.1M | ||
| Q3 25 | $31.1M | $59.0M | ||
| Q2 25 | — | $60.4M | ||
| Q1 25 | $35.2M | $57.0M | ||
| Q4 24 | $32.6M | $46.7M | ||
| Q3 24 | $24.7M | $46.1M | ||
| Q2 24 | — | $49.4M | ||
| Q1 24 | $35.7M | $49.2M |
| Q4 25 | — | $456.0K | ||
| Q3 25 | $-10.0M | $1.4M | ||
| Q2 25 | — | $116.5M | ||
| Q1 25 | $-14.8M | $250.0K | ||
| Q4 24 | $-6.6M | $7.6M | ||
| Q3 24 | $-16.2M | $-853.0K | ||
| Q2 24 | — | $91.2M | ||
| Q1 24 | $15.6M | $-2.3M |
| Q4 25 | — | — | ||
| Q3 25 | 25.0% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 28.0% | — | ||
| Q4 24 | 34.0% | — | ||
| Q3 24 | 21.8% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 33.3% | — |
| Q4 25 | — | 10.8% | ||
| Q3 25 | -9.9% | 10.0% | ||
| Q2 25 | — | 12.1% | ||
| Q1 25 | -25.7% | 8.8% | ||
| Q4 24 | -6.0% | 11.8% | ||
| Q3 24 | -46.9% | 4.6% | ||
| Q2 24 | — | — | ||
| Q1 24 | -2.5% | 8.3% |
| Q4 25 | — | 0.8% | ||
| Q3 25 | -32.1% | 2.3% | ||
| Q2 25 | — | 192.9% | ||
| Q1 25 | -42.0% | 0.4% | ||
| Q4 24 | -20.2% | 16.4% | ||
| Q3 24 | -65.7% | -1.9% | ||
| Q2 24 | — | 184.7% | ||
| Q1 24 | 43.8% | -4.7% |
| Q4 25 | — | $0.16 | ||
| Q3 25 | $-0.29 | $0.49 | ||
| Q2 25 | — | $43.67 | ||
| Q1 25 | $-0.47 | $0.08 | ||
| Q4 24 | $-0.25 | $2.71 | ||
| Q3 24 | $-0.53 | $-0.36 | ||
| Q2 24 | — | $38.40 | ||
| Q1 24 | $0.42 | $-1.00 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $18.9M | $18.4M |
| Total DebtLower is stronger | $136.0M | $113.3M |
| Stockholders' EquityBook value | $-10.5M | $188.7M |
| Total Assets | $235.2M | $588.3M |
| Debt / EquityLower = less leverage | — | 0.60× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $18.4M | ||
| Q3 25 | $18.9M | $16.6M | ||
| Q2 25 | — | $17.0M | ||
| Q1 25 | $5.4M | $13.3M | ||
| Q4 24 | $9.5M | $10.2M | ||
| Q3 24 | — | $6.3M | ||
| Q2 24 | — | $10.1M | ||
| Q1 24 | — | $5.9M |
| Q4 25 | — | $113.3M | ||
| Q3 25 | $136.0M | $111.3M | ||
| Q2 25 | — | $110.8M | ||
| Q1 25 | $124.9M | $112.0M | ||
| Q4 24 | $111.3M | $111.5M | ||
| Q3 24 | $106.3M | $95.2M | ||
| Q2 24 | — | $99.5M | ||
| Q1 24 | $97.1M | $179.7M |
| Q4 25 | — | $188.7M | ||
| Q3 25 | $-10.5M | $187.6M | ||
| Q2 25 | — | $185.6M | ||
| Q1 25 | $2.2M | $68.6M | ||
| Q4 24 | $15.4M | $66.7M | ||
| Q3 24 | $-3.9M | $56.4M | ||
| Q2 24 | — | $56.8M | ||
| Q1 24 | $17.7M | $-35.8M |
| Q4 25 | — | $588.3M | ||
| Q3 25 | $235.2M | $592.1M | ||
| Q2 25 | — | $599.0M | ||
| Q1 25 | $237.7M | $511.2M | ||
| Q4 24 | $255.4M | $530.1M | ||
| Q3 24 | $246.8M | $508.9M | ||
| Q2 24 | — | $530.5M | ||
| Q1 24 | $246.2M | $543.7M |
| Q4 25 | — | 0.60× | ||
| Q3 25 | — | 0.59× | ||
| Q2 25 | — | 0.60× | ||
| Q1 25 | 56.05× | 1.63× | ||
| Q4 24 | 7.20× | 1.67× | ||
| Q3 24 | — | 1.69× | ||
| Q2 24 | — | 1.75× | ||
| Q1 24 | 5.49× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.8M | $1.7M |
| Free Cash FlowOCF − Capex | $25.0K | $891.0K |
| FCF MarginFCF / Revenue | 0.1% | 1.6% |
| Capex IntensityCapex / Revenue | 5.6% | 1.4% |
| Cash ConversionOCF / Net Profit | — | 3.65× |
| TTM Free Cash FlowTrailing 4 quarters | $-16.8M | $14.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $1.7M | ||
| Q3 25 | $1.8M | $2.3M | ||
| Q2 25 | — | $6.8M | ||
| Q1 25 | $1.2M | $6.2M | ||
| Q4 24 | $-6.1M | $2.1M | ||
| Q3 24 | $-613.0K | $-1.3M | ||
| Q2 24 | — | $5.1M | ||
| Q1 24 | $-1.4M | $-277.0K |
| Q4 25 | — | $891.0K | ||
| Q3 25 | $25.0K | $1.9M | ||
| Q2 25 | — | $6.2M | ||
| Q1 25 | $-4.3M | $5.9M | ||
| Q4 24 | $-8.6M | $1.7M | ||
| Q3 24 | $-4.0M | $-1.4M | ||
| Q2 24 | — | $5.1M | ||
| Q1 24 | $-7.8M | $-326.0K |
| Q4 25 | — | 1.6% | ||
| Q3 25 | 0.1% | 3.2% | ||
| Q2 25 | — | 10.3% | ||
| Q1 25 | -12.1% | 10.3% | ||
| Q4 24 | -26.3% | 3.6% | ||
| Q3 24 | -16.3% | -3.0% | ||
| Q2 24 | — | 10.3% | ||
| Q1 24 | -21.8% | -0.7% |
| Q4 25 | — | 1.4% | ||
| Q3 25 | 5.6% | 0.7% | ||
| Q2 25 | — | 0.9% | ||
| Q1 25 | 15.5% | 0.6% | ||
| Q4 24 | 7.5% | 0.9% | ||
| Q3 24 | 13.9% | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | 17.8% | 0.1% |
| Q4 25 | — | 3.65× | ||
| Q3 25 | — | 1.68× | ||
| Q2 25 | — | 0.06× | ||
| Q1 25 | — | 24.80× | ||
| Q4 24 | — | 0.28× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.06× | ||
| Q1 24 | -0.09× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
RGS
| Franchise Segment | $37.9M | 66% |
| Royalty | $13.6M | 24% |
| Other | $2.8M | 5% |
| Fees | $1.8M | 3% |
| Franchise Fees | $1.0M | 2% |
